Garden State Medical Spa Scotch Plains
Garden State Medical Spa Scotch Plains · 1814 East 2nd Street · Scotch Plains, NJ 07076
4.9· 19 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- GLP-1 medications named on site
- Medically supervised weight loss
About this practice
Garden State Medical Spa Scotch Plains is a medical spa in Scotch Plains, New Jersey whose website lists a weight-loss program covering Wegovy, Ozempic, Mounjaro and Zepbound, with a questionnaire to get started. The site introduces Pooja Mehta, MD, a board-certified family medicine physician, and describes aesthetic services as well. Its Google rating is 4.9 stars across 19 reviews dating back to 2022, with 4 in the past year; the staff and results are each mentioned in 5 reviews, along with the providers' knowledge.
Services & access
| Advertises semaglutide today | Yes |
| Advertises tirzepatide today | Yes |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-06-01. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★4.9 across 19 Google reviews. Of the 16 reviews we analyzed, 16 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Friendly, helpful staff5 reviews
- Weight-loss results5 reviews
- Knowledgeable, professional providers3 reviews
- Clean, comfortable office3 reviews
Common complaints
No negative reviews among those we analyzed.
Most recent Google reviews
Chris S.★★★★★2026-06-01Helpful service
Alicia J.★★★★★2026-05-17I have had a great experience at Garden State Medical Spa! I got a six session package for Laser Hair Removal for the underarms at a great price and I've seen fantastic results after just the first 2 sessions! My technician was informative, patient, and very kind! 10/10 would recommend!
Phoebe K.★★★★★2026-05-11Absolutely amazing. Great service and results.
Ceyda S.★★★★★2026-04-06First time getting laser hair removal and honestly such a great experience here. Even after just 1 session i could see the hair getting thinner. Absolutely recommend for anyone !!
Katherine M.★★★★★2025-06-21I’ve completed 5–6 sessions of laser hair removal on my legs and lower arms, and I’m beyond thrilled with the results. The difference is incredible! I can’t speak highly enough of Eman, my technician - she’s extremely professional, knowledgeable, and always makes the experience comfortable and pleasant. Each session feels more like self-care than a chore thanks to her. Highly recommend!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs